EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Situ Complexation of sgRNA and Cas12a Improves the Performance of a One-Pot RPA–CRISPR-Cas12 Assay

Jake M Lesinski iD, Thomas Moragues, Prerit Mathur, Yang Shen iD, Carolina Paganini, Léonard Bezinge iD, Bo Verberckmoes, Bodine Van Eenooghe, Stavros Stavrakis iD, Andrew J deMello iD, Daniel A Richards iD

Analytical Chemistry · 25.06.2024 · 96 (25) · 10443-10450

DOI: 10.1021/acs.analchem.4c01777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 12.06.2024. Verfasst von Jake M Lesinski und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Chemical and Bioengineering, ETH Zurich, Vladimir-Prelog-Weg 1, 8093 Zürich, Switzerland. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, CRISPR-Associated Proteins, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eidgen?ssische Technische Hochschule Z?rich, ETH4D.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to their ability to selectively target pathogen-specific nucleic acids, CRISPR-Cas systems are increasingly being employed as diagnostic tools. "One-pot" assays that combine nucleic acid amplification and CRISPR-Cas systems (NAAT-CRISPR-Cas) in a single step have emerged as one of the most popular CRISPR-Cas biosensing formats. However, operational simplicity comes at a cost, with one-pot assays typically being less sensitive than corresponding two-step NAAT-CRISPR-Cas assays and often failing to detect targets at low concentrations. It is thought that these performance reductions result from the competition between the two enzymatic processes driving the assay, namely, Cas-mediated cis-cleavage and polymerase-mediated amplification of the target DNA. Herein, we describe a novel one-pot RPA-Cas12a assay that circumvents this issue by leveraging in situ complexation of the target-specific sgRNA and Cas12a to purposefully limit the concentration of active Cas12a during the early stages of the assay. Using a clinically relevant assay against a DNA target for HPV-16, we show how this in situ format reduces competition between target cleavage and amplification and engenders significant improvements in detection limit when compared to the traditional one-pot assay format, even in patient-derived samples. Finally, to gain further insight into the assay, we use experimental data to formulate a mechanistic model describing the competition between the Cas enzyme and nucleic acid amplification. These findings suggest that purposefully limiting cis-cleavage rates of Cas proteins is a viable strategy for improving the performance of one-pot NAAT-CRISPR-Cas assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsCRISPR-Associated ProteinsRNA, Guide, CRISPR-Cas SystemsHumansEndodeoxyribonucleasesBacterial ProteinsNucleic Acid Amplification TechniquesReplication Protein ABiosensing Techniques

Substanzen

CRISPR-Associated ProteinsRNA, Guide, CRISPR-Cas SystemsCas12a proteinEndodeoxyribonucleasesBacterial ProteinsReplication Protein A

Autor:innen und Institutionen

  • Institute for Chemical and Bioengineering, ETH Zurich, Vladimir-Prelog-Weg 1, 8093 Zürich, Switzerland.
  • Institute of Food, Nutrition and Health, ETH Zurich, Schmelzbergstrasse 7, 8092 Zürich, Switzerland.
  • Faculty of Medicine and Health Sciences, Department of Public Health and Primary Care, Ghent University, De Pintelaan 185, 9000 Gent, Belgium.

ORCID-Profile: Jake M Lesinski, Yang Shen, Léonard Bezinge, Stavros Stavrakis, Andrew J deMello, Daniel A Richards

Förderung

  • Eidgen?ssische Technische Hochschule Z?rich
  • ETH4D

Zitieren

APA

Lesinski, J. M., Moragues, T., Mathur, P., Shen, Y., Paganini, C., Bezinge, L., Verberckmoes, B., Van Eenooghe, B., Stavrakis, S., deMello, A. J., & Richards, D. A. (2024). In Situ Complexation of sgRNA and Cas12a Improves the Performance of a One-Pot RPA–CRISPR-Cas12 Assay. Analytical Chemistry, 96(25), 10443-10450. https://doi.org/10.1021/acs.analchem.4c01777

Vancouver

Lesinski JM, Moragues T, Mathur P, Shen Y, Paganini C, Bezinge L, et al. In Situ Complexation of sgRNA and Cas12a Improves the Performance of a One-Pot RPA–CRISPR-Cas12 Assay. Analytical Chemistry. 2024;96(25):10443-10450. doi:10.1021/acs.analchem.4c01777

BibTeX
@article{Lesinski2024,
  author = {Lesinski, Jake M and Moragues, Thomas and Mathur, Prerit and Shen, Yang and Paganini, Carolina and Bezinge, Léonard and Verberckmoes, Bo and Van Eenooghe, Bodine and Stavrakis, Stavros and deMello, Andrew J and Richards, Daniel A},
  title = {In Situ Complexation of sgRNA and Cas12a Improves the Performance of a One-Pot RPA–CRISPR-Cas12 Assay},
  journal = {Analytical Chemistry},
  year = {2024},
  volume = {96},
  number = {25},
  pages = {10443--10450},
  doi = {10.1021/acs.analchem.4c01777}
}
Kostenlos starten →